These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 11361869)

  • 21. FDA approves new dosing for amprenavir and ritonavir combination.
    AIDS Treat News; 2002 Mar; (378):6-7. PubMed ID: 11965920
    [No Abstract]   [Full Text] [Related]  

  • 22. FDA notifications. Alternative dosing regimen for atazanavir is approved.
    AIDS Alert; 2008 Nov; 23(11):129-30. PubMed ID: 19048649
    [No Abstract]   [Full Text] [Related]  

  • 23. Potent new AIDS drugs underscore promise of combination therapy.
    AIDS Alert; 1996 Jan; 11(1):1-4. PubMed ID: 11363225
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Saquinavir once daily.
    TreatmentUpdate; 2002; 14(4):4. PubMed ID: 12064314
    [No Abstract]   [Full Text] [Related]  

  • 25. Nelfinavir (Viracept) moves up the ranks.
    Grodeck B
    Posit Aware; 1997; 8(2):16-7. PubMed ID: 11364452
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Agenerase approved by FDA.
    Gaylord G
    Posit Living; 1999 May; 8(4):6. PubMed ID: 12492061
    [No Abstract]   [Full Text] [Related]  

  • 27. They are back.
    Res Initiat Treat Action; 1999 Oct; 5(4):19. PubMed ID: 11366940
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fortovase approved: new saquinavir formulation.
    James JS
    AIDS Treat News; 1997 Nov; (No 283):1. PubMed ID: 11364907
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Saquinavir update.
    Treat Rev; 1997 Aug; (No 25):6. PubMed ID: 11364616
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reyataz dosing options discussed. Excerpts from the FDA atazanavir hearing.
    Huff B
    GMHC Treat Issues; 2003 Jun; 17(6):8-11. PubMed ID: 12913962
    [No Abstract]   [Full Text] [Related]  

  • 31. Lower dose of ritonavir approved for use with fosamprenavir.
    Sax PE
    AIDS Clin Care; 2007 Dec; 19(12):106. PubMed ID: 18399004
    [No Abstract]   [Full Text] [Related]  

  • 32. Kaletra OK'd by FDA.
    James JS
    Posit Living; 2000 Nov; 9(9):8, 13. PubMed ID: 12154764
    [No Abstract]   [Full Text] [Related]  

  • 33. Pill burden reduced for saquinavir.
    AIDS Patient Care STDS; 2005 Feb; 19(2):128. PubMed ID: 15747430
    [No Abstract]   [Full Text] [Related]  

  • 34. New Norvir soft-gel capsule formulation approved by FDA.
    Gaylord G
    Posit Living; 1999 Aug; 8(7):11. PubMed ID: 12492076
    [No Abstract]   [Full Text] [Related]  

  • 35. New gel formulation for saquinavir.
    AIDS Patient Care STDS; 1997 Oct; 11(5):373-4. PubMed ID: 11361823
    [No Abstract]   [Full Text] [Related]  

  • 36. Head-to-head study of protease inhibitors.
    AIDS Patient Care STDS; 1998 Jan; 12(1):63-4. PubMed ID: 11361890
    [No Abstract]   [Full Text] [Related]  

  • 37. Saquinavir (Invirase).
    Treat Rev; 1996 Apr; (no 21):5. PubMed ID: 11363396
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FDA approves nelfinavir. Food and Drug Administration.
    GMHC Treat Issues; 1997 Mar; 11(3):8. PubMed ID: 11364277
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug interactions. Coming soon--a new formulation of saquinavir (Invirase).
    TreatmentUpdate; 2006; 18(3):9. PubMed ID: 17209243
    [No Abstract]   [Full Text] [Related]  

  • 40. Anti-HIV agents. A protease-only regimen--Kaletra and saquinavir.
    TreatmentUpdate; 2004; 16(3):8. PubMed ID: 17216837
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.